SEC Form D private-offering filing

Iaso Therapeutics, Inc.

Name: Iaso Therapeutics, Inc. - new SEC Form D private-offering filing, East Lansing, MI
Published: 2026-01-14

A new SEC Form D private-offering notice from East Lansing, MI, a $1,800,000 filer-stated offering target in Biotech. The source filing is one click away.

Iaso Therapeutics, Inc. Verified via SEC Form D

Michigan State University spinout developing next-generation vaccines for infectious disease and cancer using synthetic antigens on a mutant bacteriophage Qbeta virus-like-particle carrier platform.

Filed 2026-01-14Filed to raise $1,800,000First money in 2026-01-09Raised so far $570,000HQ (as filed) East Lansing, MISector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Michigan →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.